Probaco Sverige Competitors

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Medical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint

At Getinge, we are committed to meet today's health care challenges together with health care providers and life science professionals and be part of improving patients’ lives around the globe. Our offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Our journey started in the village of Getinge on the Swedish west coast back in 1904. Today, our operations cover more than 40 countries, over 12 000 employees, while our products are sold in more than 135 countries. Every single one of us is committed to our purpose to make life-saving solutions accessible for more people. Please be aware that LinkedIn is a third-party operated social media site unaffiliated with Getinge. Getinge does not control and is not responsible for the privacy or security policies or practices on this site or any third-party websites that we may link to through this site. We recommend that you carefully review the privacy and security practices of this site and any linked third-party websites. We are not responsible for the accuracy of any information, opinions, claims, or statements posted by our followers or other users of this site. Getinge reserves all rights relating to our account on this site, including, but not limited to, removing postings. While Getinge's product-related advertisement and information is intended to be disseminated only in jurisdictions where the license to market such products has been granted, Getinge has no control over how our posted content is further disseminated through LinkedIn. Therefore, as posts are shared or liked by our followers or other LinkedIn users, we have no control over the geographic reach of such posts, comments, and communications. Please, note the foregoing when reading product-related social media posts and corroborate with local representatives for product licensing.